M. Ayyappan has been given another extension as Chairman and Managing Director of HLL Lifecare by the Government of India.
Ayyappan, who began his stint with HLL in 1991 as Marketing Manager, became the Managing Director in 2003. In 2005, he became the CMD of the mini-ratna PSU, an HLL press release said here today.
“My mandate will be to continue the social interventions that HLL is making and make sure that the healthcare delivery system in our country becomes affordable to the underserved population,” Ayyappan said.
HLL has diversified into several fields — manufacture of female condoms, rapid diagnostic test kits, pharma products and sanitary napkins, apart from launching a diagnostic chain called Hindlabs, Merrygold health care franchising programme in Uttar Pradesh and setting up a joint venture with Acumen Fund to set up LifeSpring Hospitals, the release said.
HLL’s Infrastructure Development Division has built several super-speciality hospitals under Pradhan Mantri Swasthya Suraksha Yojana Phase I and is setting such hospitals at Rhotak, Aligarh and Madurai and ESIC Medical College at Quilon.
The company has also set up a world-class R&D centre at Thiruvananthapuram, it said.
HLL, now a public limited company has seen its equity base increase from Rs 15 crore to Rs 300 crore. It has also set up another subsidiary HLL Biotech Ltd to implement the Rs 595-crore integrated vaccine complex project at Chengalpet in Tamil Nadu, the release said.